A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine†

OBJECTIVE: This randomised, double-blind, 12-week study compared efficacy and tolerability of flexible-dose treatment with vortioxetine (10–20 mg/day) versus agomelatine (25–50 mg/day) in major depressive disorder patients with inadequate response to selective serotonin reuptake inhibitor (SSRI)/ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Montgomery, Stuart A, Nielsen, Rebecca Z, Poulsen, Lis H, Häggström, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265248/
https://www.ncbi.nlm.nih.gov/pubmed/25087600
http://dx.doi.org/10.1002/hup.2424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265248/
https://www.ncbi.nlm.nih.gov/pubmed/25087600
http://dx.doi.org/10.1002/hup.2424

Ejemplares similares